Generic/Brand Name Carbamazepine Classification: Anticonvulsant

Dose/Freq./Ro ute 200mg/tab BID

Mechanism of Action

Indication

Contraindication

Adverse Reaction Ataxia, drowsiness, fatigue, psychosis, syncope, vertigo, headache, worsening of seizures

Nursing Precaution

Unclear. Chemically related to tricyclic depressants (TCAs). Anticonvulsant action may result from reduction in polysynaptic responses and blocking of post-tetanic potentiation.

Prophylaxis of generalized tonicclonic, mixed, and complex-partial seizures. Trigeminal Neuralgia

Hypersensitivity to drug or TCAs. MAOI use within past 14 days. Bone marrow depression Pregnancy or breastfeeding

Chlorpromazine Classification: Antipsychotic, Anxiolytic, Antiemetic

200mg/tab 1/2

Unknown. May block postsynaptic dopamine receptors in brain and depress areas involved in wakefulness and adrenergic-blocking properties. Thought to work by affecting the activity of a natural compound called dopamine in the brain. Dopamine is known as a neurotransmitter, and is involved in transmitting messages between brain cells. It is known to be involved in regulating

Acute schizophrenia or mania

Sedation, drowsiness, extrapyramidal reactions, tardive dyskinesia, pseudoparkinso nism, seizures Pregnancy and lactation CNS depression Liver damage Renal dysfunction

Monitor patient closely Assess for history of psychosis; drug may activate symptoms Monitor baseline hematologic, kidney, and liver function test results. Assess for extrapyramidal symtoms.

Flupentixol Classification: Antipsychotic

20mg/amp IM

Maintenance therapy for chronic schizophrenia in patients whose main manifestations do not include excitement, agitation, or

Monitor for sedation and extrapyramidal responses

mood and behaviour, amongst other things. Unlike other antidepressants, flupentixol usually starts to produce an antidepressant effect within two to three days. However, it may not make you feel fully better for at least few weeks. Biperiden Hydrochloride 2mg/tab BID PRN for EPS Anticholinergic activity in the CNS that is believed to help normalize the hypothesized

hyperactivity

Relief of symptoms of EPS that accompany phenothiazine therapy

Hypersensitivity to benetropine Glaucoma, stenosing peptic ulcers Bladder neck obstruction Pregnancy and lactation Alzheimers disease

Disorientation, confusion, memory loss, hallucinations, nervousness, light headedness, dizziness, blurred vision, dry mouth, constipation, flushing, urinary retention

May impair ability to drive or operate machinery